Aarey Drugs & Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
AAREYDRUGS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Aarey Drugs & Pharmaceuticals Limited has submitted its quarterly financial results for the period ending December 31, 2025 (Q3 FY26) to the NSE. The filing is a routine compliance disclosure under listing obligations, confirming that the company has shared its earnings statement with the exchange within the stipulated timeline. The actual revenue, profit, margin, and balance sheet figures are contained in the detailed results document, which was not part of this particular announcement. Investors would need to refer to the full financial results filing to assess the company's performance for the quarter.
This is a procedural filing notification with no direct impact on shareholders or stock price. The real impact will depend on the actual numbers in the detailed results — investors should review the full financial statement for revenue, profit, and margin trends before making any decisions.